Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
Part of paid clinical trials in Tallahassee, Florida.
- Sponsor
- Florida State University
- Study ID
- NCT07784348
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 8 Years
- Healthy Volunteers
- Not accepted
Interventions
- Central executive training — BEHAVIORALComputerized, adaptive central executive working memory training protocol
- Behavioral parent training — BEHAVIORALBehavioral parent training
Study Details
Initial non-randomized trial of behavioral parent training (BPT) compared to central executive training (CET), followed by a randomized controlled trial of CET+BPT for young children with ADHD.
Key Dates
- First listed
- Aug 25, 2026
- Start date
- May 1, 2024
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Central executive training
- Active Comparator: Behavioral parent training
- Other: Central executive training + concurrent behavioral parent training
- No Intervention: Treatment as usual/waitlist
Primary Outcome Measure
ADHD Rating Scale (ADHD-RS) [ Time Frame: Change from baseline to immediate post-treatment and maintenance of gains up to 3 months after treatment completion ]
Central Contacts
- Children's Learning Clinic850-645-7423
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Learning Clinic at Florida State University | Tallahassee | Florida | 32306 | Michael Kofler, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Tallahassee, FL
By condition
By specialty
Related Studies
- Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHDPHASE4 · Recruiting · Icahn School of Medicine at Mount Sinai · Gainesville, Florida
- Central Executive Training and Parent Training for ADHDRecruiting · Florida State University · Tallahassee, Florida
- A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHDPHASE3 · Recruiting · Axsome Therapeutics, Inc. · Dothan, Alabama
- A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHDPHASE3 · Recruiting · Axsome Therapeutics, Inc. · Dothan, Alabama